IRIS - Res&Arch Institutional Research Information System - Research & Archive

ANGELI, FABIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.043
AS - Asia 1.519
EU - Europa 1.415
SA - Sud America 257
Continente sconosciuto - Info sul continente non disponibili 99
AF - Africa 32
OC - Oceania 7
Totale 5.372
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.994
SG - Singapore 713
IE - Irlanda 254
UA - Ucraina 216
HK - Hong Kong 209
IT - Italia 204
CN - Cina 203
RU - Federazione Russa 203
BR - Brasile 202
SE - Svezia 183
VN - Vietnam 174
FI - Finlandia 86
DE - Germania 82
FR - Francia 79
IN - India 38
BD - Bangladesh 33
GB - Regno Unito 32
TR - Turchia 26
AR - Argentina 22
CA - Canada 22
KR - Corea 22
PK - Pakistan 17
AT - Austria 13
IQ - Iraq 13
MX - Messico 11
UZ - Uzbekistan 11
CH - Svizzera 10
ID - Indonesia 10
VE - Venezuela 10
NL - Olanda 9
BE - Belgio 8
ZA - Sudafrica 8
JP - Giappone 7
PL - Polonia 7
CO - Colombia 6
EC - Ecuador 6
JO - Giordania 6
TN - Tunisia 6
ES - Italia 5
JM - Giamaica 4
KZ - Kazakistan 4
MA - Marocco 4
MY - Malesia 4
NZ - Nuova Zelanda 4
PY - Paraguay 4
AE - Emirati Arabi Uniti 3
DZ - Algeria 3
EG - Egitto 3
GR - Grecia 3
IL - Israele 3
LB - Libano 3
LT - Lituania 3
PH - Filippine 3
AU - Australia 2
AZ - Azerbaigian 2
BG - Bulgaria 2
BO - Bolivia 2
BY - Bielorussia 2
CL - Cile 2
CZ - Repubblica Ceca 2
EE - Estonia 2
GT - Guatemala 2
HU - Ungheria 2
KG - Kirghizistan 2
LY - Libia 2
ME - Montenegro 2
NI - Nicaragua 2
PA - Panama 2
PE - Perù 2
SA - Arabia Saudita 2
TH - Thailandia 2
UG - Uganda 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BF - Burkina Faso 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CU - Cuba 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EU - Europa 1
GE - Georgia 1
HR - Croazia 1
KE - Kenya 1
KH - Cambogia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MG - Madagascar 1
NP - Nepal 1
NR - Nauru 1
OM - Oman 1
PS - Palestinian Territory 1
RO - Romania 1
RS - Serbia 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 5.274
Salva come PNG Salva come JPEG
Città #
Singapore 495
Chandler 295
Dublin 254
Hong Kong 206
San Jose 189
San Mateo 140
Jacksonville 136
Ashburn 126
Dong Ket 107
Altamura 91
Boardman 90
Santa Clara 88
Princeton 70
Medford 69
Beijing 67
Lawrence 67
Moscow 63
Lauterbourg 60
Wilmington 57
Perugia 48
New York 30
Ann Arbor 24
Ho Chi Minh City 24
Los Angeles 24
Helsinki 23
Seoul 22
Andover 21
São Paulo 18
The Dalles 17
Hanoi 16
Saint Petersburg 16
Des Moines 15
Izmir 11
Norwalk 11
Brooklyn 10
Chennai 10
Atlanta 9
Falls Church 9
Munich 9
Phoenix 9
Rio de Janeiro 9
San Paolo di Civitate 9
Shanghai 9
Chicago 8
Redwood City 8
Belo Horizonte 7
Denver 7
Montreal 7
Toronto 7
Amman 6
Amsterdam 6
Brussels 6
Columbus 6
Piscataway 6
Rome 6
Tokyo 6
Woodbridge 6
Baghdad 5
Council Bluffs 5
Frankfurt am Main 5
Johannesburg 5
Lahore 5
London 5
Mexico City 5
Porto Alegre 5
Tashkent 5
Vienna 5
Warsaw 5
Amelia 4
Ankara 4
Cagliari 4
Caxias do Sul 4
Goiânia 4
Houston 4
Karachi 4
New Delhi 4
Nuremberg 4
Orem 4
San Diego 4
San Francisco 4
Seattle 4
Asunción 3
Bauru 3
Caracas 3
Curitiba 3
Dallas 3
Dhaka 3
Falkenstein 3
Guayaquil 3
Hangzhou 3
Kaifeng 3
Kuala Lumpur 3
Manchester 3
Medellín 3
Miami 3
Mumbai 3
Ottawa 3
Piracicaba 3
Redmond 3
Ribeirão Preto 3
Totale 3.329
Salva come PNG Salva come JPEG
Nome #
Prehypertension and Cardiometabolic Syndrome 145
Adverse prognostic significance of new diabetes in treated hypertensive subjects 120
Aliskiren versus ramipril in hypertension. 117
Choice of ACE inhibitor combinations in hypertensive patients with type 2 diabetes: update after recent clinical trials. 107
Day-Night Dip and Early-Morning Surge in Blood Pressure in Hypertension: Prognostic Implications 107
Beta-blockers and risk of all-cause mortality in non-cardiac surgery. 106
Above which blood pressure level does the risk of atrial fibrillation increase? 105
Angiotensin-converting enzyme inhibitors 97
Improved cardiovascular risk stratification by a simple ECG index in hypertension 97
New-onset diabetes, antihypertensive treatment, and outcome 96
Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and protection from stroke. 94
Effects of intensive blood pressure reduction on myocardial infarction and stroke in diabetes: a meta-analysis in 73,913 patients 94
Optimal therapy in hypertensive subjects with diabetes mellitus 94
Meta-Analysis of effectiveness or lack thereof of angiotensin-converting enzyme inhibitors for prevention of heart failure in patients with systemic hypertension 94
Microalbuminuria and hypertension. 93
Amlodipine and celecoxib for treatment of hypertension and osteoarthritis pain 93
Atrial fibrillation and mortality in patients with acute myocardial infarction: a systematic overview and meta-analysis. 89
Exploring the optimal combination therapy in hypertensive patients with diabetes mellitus. 88
Beyond blood pressure: evidence for cardiovascular, cerebrovascular, and renal protective effects of renin-angiotensin system blockers. 88
Long-term outcome in patients with non-valvular atrial fibrillation on dabigatran: a prospective cohort study 88
Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomised trial. 87
Blood pressure lowering in diabetic patients. 86
Cystatin C and risk of mortality among patients undergoing percutaneous coronary intervention 86
Betabloccanti e ipertensione arteriosa. Evidence-based medicine o eccessivo accanimento? 86
Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: a meta-analysis. 85
Angiotensin receptor blockers in hypertension. New insights from Japan. 85
Quali novità nella gestione dell’ipertensione arteriosa dopo le recenti linee guida europee e nordamericane? 83
Impact of blood pressure variability on cardiac and cerebrovascular complications in hypertension 82
Optimizing the definition of dippers and nondippers: is a 70-86% full glass empty? 81
Home Blood Pressure Measurements Will Not Replace 24-Hour Ambulatory Blood Pressure Monitoring. 81
Lowering blood pressure with β-blockers in peripheral artery disease: the importance of comorbidity 79
Validation of the A&D UA-774 (UA-767Plus) device for self-measurement of blood pressure. 79
New-onset diabetes in treated hypertensive patients 79
Pharmacokinetic, pharmacodynamic and clinical evaluation of aliskiren for hypertension treatment. 76
"From apennines to andes:" does body mass index affect the relationship between age and blood pressure? 76
Comparative assessment of angiotensin receptor blockers in different clinical settings. 75
Home Blood Pressure Measurements Will or Will Not Replace 24-Hour Ambulatory Blood Pressure Measurement. 73
Telmisartan for the reduction of cardiovascular morbidity and mortality. 73
Hypertrophy at ECG and its regression during treatment survey (HEART survey). Rationale, design and baseline characteristics of patients. 73
Tight blood pressure control in diabetes: evidence-based review of treatment targets in patients with diabetes. 72
Modernization and hypertension: is the link changing? 72
Risk Prediction Models for Hypertensive Disorders of Pregnancy: Role of 12-Lead Electrocardiography 72
Modern treatment of patients at risk: stilla HOPE for ACE inhibitors? 72
Safety and efficacy of aliskiren in the treatment of hypertension and associated clinical conditions. 69
Finding a place for aliskiren in the wide spectrum of blood pressure lowering agents. 69
The voltage of R wave in lead aVL improves risk stratification in hypertensive patients without ECG left ventricular hypertrophy. 68
Diuretic treatment of hypertension 67
PK/PD evaluation of fimasartan for the treatment of hypertension Current evidences and future perspectives 66
Perioperative beta blockade: the debate continues. 64
White-coat hypertension in adults. 64
Good news for beta-blockers in perioperative medicine. 61
Statins in acute coronary syndrome: very early initiation and benefits. 61
Pharmacokinetic evaluation and clinical utility of azilsartan medoxomil for the treatment of hypertension. 61
Short- and Long-Term Incidence of Stroke in White-Coat Hypertension 59
Fixed-dose combination therapy in hypertension: cons. 58
Role and prognostic value of individual ambulatory blood pressure components in chronic kidney disease 57
Hypertension around the world: new insights from developing countries. 56
Neutrophil count and ambulatory pulse pressure as predictors of cardiovascularadverse events in postmenopausal women with hypertension 56
Multivariable analysis in cerebrovascular research: practical notes for the clinician. 55
Prognostic value of lipoprotein fractions in essential hypertension. 54
What to Do When Blood Pressure Is Between 130/80 and 139/89 mm Hg? 54
Hypertension and the J-curve phenomenon: implications for tight blood pressure control 53
Unattended compared to traditional blood pressure measurement in patients with rheumatoid arthritis: a randomised cross-over study 53
More than a REASON to use arterial stiffness as risk marker and therapeutic target in hypertension 52
Very early initiation of statin therapy and mortality in patients with acute coronary syndrome. 52
Protein intake in type 1 diabetes: putting controversies into perspectives. 52
II monitoraggio ambulatoriale della pressione arteriosa nella pratica clinica 47
Tight Blood Pressure Control Saves Lives in Hypertensive Patients With Chronic Kidney Disease 47
Mecanismos de la hipertrofia ventricular izquierda en la hipertensión: Más que solo la presión arterial 46
Is hydrochlorothiazide more effective on LVH in nonresponders to losartan than in those to atenolol? 46
Totale 5.372
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.860
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.860
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022463 0 86 18 35 11 5 1 167 4 3 61 72
2022/2023969 71 218 8 65 89 87 3 62 310 4 37 15
2023/2024325 24 44 17 5 5 1 58 2 38 10 46 75
2024/2025765 4 76 29 51 105 35 50 34 146 42 151 42
2025/20261.731 118 115 120 181 236 138 336 99 178 126 69 15
2026/202793 38 55 0 0 0 0 0 0 0 0 0 0
Totale 5.372